Ani Pharmaceuticals reported $52.06M in Sales Revenues for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Abbvie ABBV:US $ 14342M 383M
Aerie Pharmaceuticals AERI:US $ 29.31M 2.13M
Ani Pharmaceuticals ANIP:US $ 52.06M 3.44M
Aurora Cannabis Inc ACB:CN 60.11M 5.5M
Biodelivery Sciences International BDSI:US $ 41.09M 0.35M
Canopy Growth Corp WEED:CN C$ 131.37M 4.84M
Depomed DEPO:US $ 25.47M 0.1M
Eli Lilly And LLY:US $ 6772.8M 32.7M
Emergent Biosolutions EBS:US $ 329M 68.5M
Endo International Ordinary Shares ENDP:US $ 772.03M 58.2M
Flexion Therapeutics FLXN:US $ 21.33M 6.85M
Heron Therapeutics HRTX:US $ 23.23M 0.79M
Hikma Pharmaceutical HIK:LN 1.22B 7M
Knight Therapeutics Inc GUD:CN C$ 73.34M 7.54M
Lannett LCI:US $ 101.52M 4.48M
Nektar Therapeutics NKTR:US $ 24.92M 3.41M
Novartis NVS:US $ 13367M 73M
Omeros OMER:US $ 30M 1.18M
Perrigo Ordinary Shares PRGO:US $ 1042.7M 61.6M
Sun Pharmaceuticals SUNP:IN IR 96259.3M 928.1M
Teva Pharmaceutical TEVA:IT 3.89B 23M
Teva Pharmaceutical Industries TEVA:US $ 3887M 23M